Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker.
Ontology highlight
ABSTRACT: Prostate cancer (PC) remains the most common malignancy and the second most common cause of cancer death in men. As a result of highly variable biological behavior and development of resistance to available agents under therapeutic pressure, optimal management is often unclear. Traditional surgical biopsies, even when augmented by genomic studies, may fail to provide adequate guidance for clinical decisions as these can only provide a snapshot of a dynamic process. Additionally, surgical biopsies are cumbersome to perform repeatedly and often involve risk. Liquid biopsies (LB) are defined as the analysis of either corpuscular (circulating tumor cells, extracellular vesicles) or molecular (circulating DNA or RNA) tumor-derived material. LB could more precisely identify clinically relevant a
SUBMITTER: Ionescu F
PROVIDER: S-EPMC8996910 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA